SpartanNash Co
F:SRJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SpartanNash Co
F:SRJ
|
US |
|
Tatton Asset Management PLC
F:2T7
|
UK |
|
Healios KK
F:6VX
|
JP |
|
M
|
Martinrea International Inc
F:03M
|
CA |
|
B
|
Banco Santander-Chile
F:BSA
|
CL |
|
V Technology Co Ltd
OTC:VCHYF
|
JP |
|
Redwoods Acquisition Corp
NASDAQ:WENA
|
US |
|
Union Jack Oil PLC
OTC:UJOGF
|
UK |
|
E
|
Esprit Holdings Ltd
SWB:ESHB
|
HK |
|
Oncopeptides AB
F:OND
|
SE |
|
A
|
Acciona SA
XMUN:AJ3
|
ES |
|
Bechtle AG
OTC:BECTY
|
DE |
|
PCC Rokita SA
F:229
|
PL |
|
C
|
Computer and Technologies Holdings Ltd
F:CVB
|
HK |
|
I
|
InstallatoerGruppen A/S
CSE:IG
|
DK |
|
Nfl Biosciences SAS
F:82F
|
FR |
|
Tomy Co Ltd
OTC:TOMYF
|
JP |
|
Z
|
Zemaitijos Pienas AB
XMUN:IU8
|
LT |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SRJ's stock price target?
Not Available
SRJ does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for SpartanNash Co?
Projected CAGR
2%
Over the last 10 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for SpartanNash Co?
Projected CAGR
0%
Over the last 10 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 0%.